Novel antiproliferative agents bearing morpholinopyrimidine scaffold as PI3K inhibitors and apoptosis inducers; design, synthesis and molecular docking
作者:Amira A. Helwa、Nehad M. El-Dydamony、Rasha A. Radwan、Sahar M. Abdelraouf、Rana M. Abdelnaby
DOI:10.1016/j.bioorg.2020.104051
日期:2020.9
active compounds 6e, 6g, and 6l against the most sensitive cell line leukemia SR were estimated (IC50 = 0.76, 13.59, and 4.37 uM, respectively). To investigate their PI3K enzyme inhibition activity, the assay was done on Class IA (α, β, & δ) isoforms. The IC50 values were very promising: compound [6e = 11.73 (α), 6.09 (β), 11.18 (δ)], compound [6g = 8.43 (α), 15.84 (β), 30.62 (δ)], and compound [6l = 13
合成了两个新的吗啉代嘧啶衍生物系列,并由美国国家癌症研究所筛选了它们对60种肿瘤细胞系的体外细胞毒性活性。在体外的细胞毒性IC 50为最活跃的化合物的值6e中,6克和6升估计针对最敏感的细胞系白血病SR(IC 50 = 0.76,13.59和4.37微米,分别地)。为了研究其PI3K酶抑制活性,对IA类(α,β和δ)同工型进行了测定。IC 50值非常有前途:化合物[ 6e = 11.73(α),6.09(β),与化合物相比,化合物11.6(δ)],化合物[ 6g = 8.43(α),15.84(β),30.62(δ)]和化合物[ 6l = 13.98(α),7.22(β),10.94(δ)]。参考化合物LY294002 = 6.28(α),4.51(β),4.60(δ)uM。此外,对白血病SR进行细胞周期分析和膜联蛋白V-FITC染色,在G2 / M期停滞并诱导凋亡。最后,